Homyk
Homyk v. ChemoCentryx, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 JONNIE HOMYK, et al., Case No.21-cv-03343-JST Plaintiffs,
ORDERRESOLVINGMOTIONS TO
v. EXCLUDE CHEMOCENTRYX, INC., et al., Re: ECF No. 188, 190, 191, 193–99, 206 Defendants. REDACTED VERSION 11 12 Before the Court are the parties’ motions to exclude evidence under Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). This order addresses Defendants ChemoCentryx, Inc. (“ChemoCentryx”) and Dr. Thomas J. Schall’s (together, “Defendants”) motions to exclude testimony of Dr. Alan Bonder, Dr. Simon Helfgott, Dr. David Madigan, and Dr. Matthew Cain, and Lead Plaintiff Indiana Public Retirement System’s motions to exclude testimony of Dr. Anisha Dua, Dr. Naga Chalasani, Dr. Lindsay Lally, Dr. Steven Weisman, Dr. Robert Gibbons, Dr. Anupam Jena, and Mr. Carl Seiden. ECF Nos. 188, 190, 191, 193–99, 206. The Court will deny the motion as to Cain and grant the motions as to Jenaand Lally. The Court will grant in part and deny in part…